FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity

Brinkmann, 2001, FTY720: Altered lymphocyte traffic results in allograft protection, Transplantation, 72, 764, 10.1097/00007890-200109150-00002

Chiba, 1998, FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing, J Immunol, 160, 5037, 10.4049/jimmunol.160.10.5037

Pinschewer, 2000, FTY720 immunosuppression impairs effector T-cell peripheral homing without affecting induction, expansion, and memory, J Immunol, 164, 5761, 10.4049/jimmunol.164.11.5761

Brinkmann, 2001, FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression, Transplant Proc, 33, 530, 10.1016/S0041-1345(00)02126-6

Fujita, 1994, Fungal metabolites. Part 11. A potent immunosuppressive activity found in Isaria sinclairii metabolite, J Antibiot, 47, 208, 10.7164/antibiotics.47.208

Kiuchi, 1998, Synthesis and biological evaluation of 2,2-disubstituted 2-aminoethanols: analogues of FTY720, Bioorg Med Chem Lett, 8, 101, 10.1016/S0960-894X(97)10188-3

Kiuchi, 2000, Synthesis and immunosuppressive activity of 2-substituted 2-aminopropane-1,3-diols and 2-aminoethanols, J Med Chem, 43, 2946, 10.1021/jm000173z

Hla, 2001, Lysophospholipids — receptor revelations, Science, 294, 1875, 10.1126/science.1065323

Lynch, 1999, Life on the edge, Trends Pharmacol Sci, 20, 473, 10.1016/S0165-6147(99)01401-7

Goetzl, 1998, Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate, FASEB J, 12, 1589, 10.1096/fasebj.12.15.1589

English, 2000, Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis, FASEB J, 14, 2255, 10.1096/fj.00-0134com

Kimura, 2001, Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells, J Biol Chem, 276, 31780, 10.1074/jbc.M104353200

Brinkmann, 2002, The immune modulator FTY720 targets sphingosine 1-phosphate receptors, J Biol Chem, 277, 21453, 10.1074/jbc.C200176200

Mandala, 2002, Alteration of lymphocyte trafficking by sphingosine 1-phosphate receptor agonists, Science, 296, 346, 10.1126/science.1070238

Nikolova, 2000, Prevention of graft vessel disease by combined FTY720 and Cyclosporin A treatment in the DA to Lewis rat carotid artery transplantation model, Transplantation, 69, 2525, 10.1097/00007890-200006270-00010

Häyry, 1998, Chronic rejection: risk factors, regulation, and possible sites of therapeutic intervention, Transplant Proc, 30, 2407, 10.1016/S0041-1345(98)00670-8

Korbutt, 1997, Islet transplantation, Adv Exp Med Biol, 426, 397, 10.1007/978-1-4899-1819-2_53

Yamasaki, 1998, Effect of a new immunosuppressive agent, FTY720, on survival of islet allografts, Cell Transplant, 7, 403, 10.1016/S0963-6897(98)00021-9

Fu, 2002, Longterm islet graft survival in STZ and autoimmune induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720, Transplantation, 73, 1425, 10.1097/00007890-200205150-00011

Matsuura, 2000, Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen-induced arthritis in rats, Int J Immunopharmacol, 22, 323, 10.1016/S0192-0561(99)00088-0

Kitabayashi, 2000, FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes, J Cardiovasc Pharmacol, 35, 410, 10.1097/00005344-200003000-00010

Kurose, 2000, Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats, Exp Eye Res, 70, 7, 10.1006/exer.1999.0777

Miyamoto, 2001, Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis, J Am Coll Cardiol, 37, 1713, 10.1016/S0735-1097(01)01204-9

Yanagawa, 1998, FTY720, a novel immunosuppressant possessing unique mechanisms. II. FTY720 prolongs skin allograft survival by decreasing T-cell infiltration into grafts but not cytokine production in vivo, J Immunol, 160, 5493, 10.4049/jimmunol.160.11.5493

Hwang, 1999, FTY720, a new immunosuppressant, promotes long term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation, Circulation, 100, 1322, 10.1161/01.CIR.100.12.1322

Chiba, 1996, FTY720, a novel immunosuppressant possessing unique mechanisms. I. Prolongation of skin allograft survival and synergistic effect in combination with CsA in rats, Transplant Proc, 28, 1056

Bai, 2002, L-selectin-dependent lymphoid occupancy is required to induce alloantigen-specific tolerance, J Immunol, 168, 1579, 10.4049/jimmunol.168.4.1579

Brinkmann, 2000, FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation, Trends Pharmacol Sci, 21, 49, 10.1016/S0165-6147(99)01419-4

Chen, 2001, FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines, Transplant Proc, 33, 3057, 10.1016/S0041-1345(01)02306-5

Kunkel, 2002, Chemokines and the tissue-specific migration of lymphocytes, Immunity, 16, 1, 10.1016/S1074-7613(01)00261-8

Henning, 2001, CC chemokine receptor 7-dependent and -independent pathways for lymphocyte homing: modulation by FTY720, J Exp Med, 194, 1875, 10.1084/jem.194.12.1875

Yagi, 2000, Immunosuppressant FTY720 inhibits thymocyte emigration, Eur J Immunol, 30, 1435, 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O

Lee, 1999, Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate, Cell, 99, 301, 10.1016/S0092-8674(00)81661-X

Beer, 2000, EDG receptors as a therapeutic target in the nervous system, Ann NY Acad Sci, 905, 118, 10.1111/j.1749-6632.2000.tb06544.x

Nagahara, 2000, Immunosuppressant FTY720 induces apoptosis by direct induction of permeability transition and release of cytochrome c from mitochondria, J Immunol, 165, 3250, 10.4049/jimmunol.165.6.3250

Matsuda, 1999, Differential activation of c-Jun NH2-terminal kinase and p38 pathways during FTY720-induced apoptosis of T lymphocytes that is suppressed by the extracellular signal-regulated kinase pathway, J Immunol, 162, 3321, 10.4049/jimmunol.162.6.3321

Brinkmann, 2001, FTY720: dissection of membrane receptor-operated, stereospecific effects on cell migration from receptor-independent antiproliferative and apoptotic effects, Transplant Proc, 33, 3078, 10.1016/S0041-1345(01)02312-0

Liliom, 2001, Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors, Biochem J, 355, 189, 10.1042/0264-6021:3550189

Mazurais, 2002, Cell type-specific localization of human cardiac S1P receptors, J Histochem Cytochem, 50, 661, 10.1177/002215540205000507